metaraminol has been researched along with Anomalous Ventricular Excitation Syndrome in 2 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laniado, S | 1 |
| Kronzon, I | 1 |
| Mehta, SS | 1 |
| Hunt, WH | 1 |
| Buckner, EE | 1 |
2 other studies available for metaraminol and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
Pulmonary edema: a complication of metaraminol treatment of paroxysmal supraventricular tachycardia.
Topics: Adolescent; Adult; Atrioventricular Node; Blood Pressure; Cardiac Output; Electrocardiography; Femal | 1974 |
Bleeding after cardiac catheterization.
Topics: Aged; Diagnosis, Differential; Digoxin; Electrocardiography; Female; Humans; Metaraminol; Tachycardi | 1969 |